Sign up to the UK Share Picking Game

Oxford Biomedica (OXB) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Oxford Biomedica

Members only

To view this content and much more please Sign Up


NOTE: This is based on 122 open tips for Oxford Biomedica (OXB)


Oxford Biomedica (OXB)
Latest Quote Price

–

Oxford Biomedica (OXB)
Price Change (%)

–


Latest Bid : – Latest Ask : –
High Today : – Low Today : –
This Years High : – This Years Low : –
Volume : – MKT Cap : –
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Stock Splits and Consolidations

30/05/2018 – Stock Consolidation 50.000:1.000


Oxford Biomedica (OXB) Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Oxford Biomedica (OXB) Latest Tips

Type Tipster SectorScore Start date Performance
– Liberum Capital – 2023-09-26 16:30:00 26/09/2023 –
– JP Morgan – 2023-09-22 04:58:00 22/09/2023 –
– Liberum Capital – 2023-09-04 08:19:00 04/09/2023 –
– Numis – 2023-06-29 09:44:00 29/06/2023 –
– JP Morgan – 2023-06-21 05:00:00 21/06/2023 –

Oxford Biomedica (OXB) Data Charts

Premium Charts

Oxford Biomedica (OXB) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : – Latest Ask : –
High Today : – Low Today : –
This Years High : – This Years Low : –
Volume : – MKT Cap : –

Oxford Biomedica Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Oxford Biomedica Tips

Type Tipster SectorScore Start date Performance
– Liberum Capital – 2023-09-26 16:30:00 26/09/2023 –
– JP Morgan – 2023-09-22 04:58:00 22/09/2023 –
– Liberum Capital – 2023-09-04 08:19:00 04/09/2023 –
– Numis – 2023-06-29 09:44:00 29/06/2023 –
– JP Morgan – 2023-06-21 05:00:00 21/06/2023 –

Stock Splits and Consolidations

30/05/2018 – Stock Consolidation 50.000:1.000